91 related articles for article (PubMed ID: 33300324)
1. The effect of neuromuscular blocking agents uses in acute respiratory distress syndrome: a systematic review and meta-analysis of randomized controlled trials.
Lyu T; Lee YS; Dhanvijay S; Freebairn R
Minerva Anestesiol; 2021 Mar; 87(3):341-350. PubMed ID: 33300324
[TBL] [Abstract][Full Text] [Related]
2. Management of Neuromuscular Blocking Agents in Critically Ill Patients with Lung Diseases.
Iavarone IG; Al-Husinat L; Vélez-Páez JL; Robba C; Silva PL; Rocco PRM; Battaglini D
J Clin Med; 2024 Feb; 13(4):. PubMed ID: 38398494
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and Safety of Glucocorticoid in the Treatment of Acute Respiratory Distress Syndrome caused by Covid-19: A Systematic Review and Meta-Analysis.
Jiang X; Zhao C; Hu W; Lu D; Chen C; Gong S; Yan J; Mao W
Clin Invest Med; 2023 Dec; 46(4):E03-E18. PubMed ID: 38330183
[TBL] [Abstract][Full Text] [Related]
4. Critical Care Pharmacist Attitudes and Perceptions of Neuromuscular Blocker Infusions in ARDS.
Devlin JW; Train SE; Burns KEA; Massaro A; Wu TT; Castor T; Vassaur J; Selvan K; Kress JP; Erstad BL
Ann Pharmacother; 2023 Nov; 57(11):1282-1290. PubMed ID: 36946587
[TBL] [Abstract][Full Text] [Related]
5. Enteral Nutrition Safety and Outcomes of Patients with COVID-19 on Continuous Infusion of Neuromuscular Blockers: A Retrospective Study.
Al-Dorzi HM; Yaqoub R; Alalmaee R; Almutairi G; Almousa A; Aldawsari L
J Nutr Metab; 2023; 2023():8566204. PubMed ID: 37415869
[TBL] [Abstract][Full Text] [Related]
6. Prolonged use of neuromuscular blocking agents is associated with increased long-term mortality in mechanically ventilated medical ICU patients: a retrospective cohort study.
Lin C; Chao WC; Pai KC; Yang TY; Wu CL; Chan MC
J Intensive Care; 2023 Nov; 11(1):55. PubMed ID: 37978572
[TBL] [Abstract][Full Text] [Related]
7. Neuromuscular Blocking Agent Use in Critical Care Transport Not Associated With Intubation.
Esteves AM; Fjeld KJ; Yonan AS; Roginski MA
Air Med J; 2024; 43(4):328-332. PubMed ID: 38897696
[TBL] [Abstract][Full Text] [Related]
8. Neuromuscular blocking agent re-exposure in a retrospective cohort with neuromuscular blocking agent-associated anaphylaxis.
Jeong J; Yun JE; Kim HJ; Jang JY; Seo JH; Lee SY; Kim WH; Seo JH; Kang HR
Ann Allergy Asthma Immunol; 2023 Nov; 131(5):637-644.e1. PubMed ID: 37356714
[TBL] [Abstract][Full Text] [Related]
9. Early Neuromuscular Blockade in Children with Pediatric Acute Respiratory Distress Syndrome.
Chandra S; Goel S; Dawra R
J Pediatr Intensive Care; 2020 Sep; 9(3):201-206. PubMed ID: 32685248
[TBL] [Abstract][Full Text] [Related]
10. Rescue Neuromuscular Blockade in Acute Respiratory Distress Syndrome Should Not Be Flat Dose.
Flannery AH; Moss M
Crit Care Med; 2020 Apr; 48(4):588-590. PubMed ID: 32205606
[No Abstract] [Full Text] [Related]
11. Ulinastatin for acute lung injury and acute respiratory distress syndrome: A systematic review and meta-analysis.
Leng YX; Yang SG; Song YH; Zhu X; Yao GQ
World J Crit Care Med; 2014 Feb; 3(1):34-41. PubMed ID: 24834400
[TBL] [Abstract][Full Text] [Related]
12. Rescue Neuromuscular Blockade in Acute Respiratory Distress Syndrome Should Be Flat Dose.
Co I; Hyzy RC
Crit Care Med; 2020 Apr; 48(4):591-593. PubMed ID: 32205607
[No Abstract] [Full Text] [Related]
13. Elevated ferritin, mediated by IL-18 is associated with systemic inflammation and mortality in acute respiratory distress syndrome (ARDS).
Mehta P; Samanta RJ; Wick K; Coll RC; Mawhinney T; McAleavey PG; Boyle AJ; Conlon J; Shankar-Hari M; Rogers A; Calfee CS; Matthay MA; Summers C; Chambers RC; McAuley DF; O'Kane CM
Thorax; 2024 Feb; 79(3):227-235. PubMed ID: 38148147
[TBL] [Abstract][Full Text] [Related]
14. Optimal Prone Position Duration in Patients With ARDS Due to COVID-19: The Omelette Pilot Trial.
Sáez de la Fuente I; Marcos Morales A; Muñoz Calahorro R; Álvaro Valiente E; Sánchez-Bayton Griffith M; Chacón Alves S; Molina Collado Z; González de Aledo AL; Martín Badía I; González Fernández M; Orejón García L; Arribas López P; Temprano Vázquez S; Sánchez Izquierdo Riera JÁ
Respir Care; 2024 Mar; ():. PubMed ID: 38531637
[TBL] [Abstract][Full Text] [Related]
15. Design and rationale of the CHILL phase II trial of hypothermia and neuromuscular blockade for acute respiratory distress syndrome.
Shanholtz CB; Terrin ML; Harrington T; Chan C; Warren W; Walter R; Armstrong F; Marshall J; Scheraga R; Duggal A; Formanek P; Baram M; Afshar M; Marchetti N; Singla S; Reilly J; Knox D; Puri N; Chung K; Brown CH; Hasday JD
Contemp Clin Trials Commun; 2023 Jun; 33():101155. PubMed ID: 37228902
[TBL] [Abstract][Full Text] [Related]
16. Molecular Phenotypes of Acute Respiratory Distress Syndrome in the ROSE Trial Have Differential Outcomes and Gene Expression Patterns That Differ at Baseline and Longitudinally over Time.
Sinha P; Neyton L; Sarma A; Wu N; Jones C; Zhuo H; Liu KD; Sanchez Guerrero E; Ghale R; Love C; Mick E; Delucchi KL; Langelier CR; Thompson BT; Matthay MA; Calfee CS
Am J Respir Crit Care Med; 2024 Apr; 209(7):816-828. PubMed ID: 38345571
[No Abstract] [Full Text] [Related]
17. Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome.
Gallo de Moraes A; El-Yafawi R; Oeckler RA
N Engl J Med; 2019 Aug; 381(8):787. PubMed ID: 31433934
[No Abstract] [Full Text] [Related]
18. Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome.
Aquino Esperanza J; de Haro C; Blanch L
N Engl J Med; 2019 Aug; 381(8):785-786. PubMed ID: 31433932
[No Abstract] [Full Text] [Related]
19. Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome.
Brink M; Everaars N; de Pont AJM
N Engl J Med; 2019 Aug; 381(8):785. PubMed ID: 31433931
[No Abstract] [Full Text] [Related]
20. Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome. Reply.
Moss M; Ulysse CA; Angus DC;
N Engl J Med; 2019 Aug; 381(8):787-788. PubMed ID: 31433935
[No Abstract] [Full Text] [Related]
[Next] [New Search]
